LEVONORGESTREL AND ETHINYL ESTRADIOL AND FERROUS FUMARATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Levonorgestrel And Ethinyl Estradiol And Ferrous Fumarate, and when can generic versions of Levonorgestrel And Ethinyl Estradiol And Ferrous Fumarate launch?
Levonorgestrel And Ethinyl Estradiol And Ferrous Fumarate is a drug marketed by Xiromed and is included in one NDA.
The generic ingredient in LEVONORGESTREL AND ETHINYL ESTRADIOL AND FERROUS FUMARATE is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
Summary for LEVONORGESTREL AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | LEVONORGESTREL AND ETHINYL ESTRADIOL AND FERROUS FUMARATE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for LEVONORGESTREL AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
US Patents and Regulatory Information for LEVONORGESTREL AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Xiromed | LEVONORGESTREL AND ETHINYL ESTRADIOL AND FERROUS FUMARATE | ethinyl estradiol; levonorgestrel | TABLET;ORAL | 214640-001 | Aug 16, 2023 | AB3 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |